meglumine has been researched along with Uterine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pravdin, EV; Uzlova, TV; Volchegorskiĭ, IA | 1 |
| Hirai, Y; Hiramatsu, Y; Hirano, Y; Kubo, K; Okada, S; Sawano, S; Yamada, K; Yamashita, T | 1 |
1 trial(s) available for meglumine and Uterine Diseases
| Article | Year |
|---|---|
[Effect of 3-oxypyridine and succinic acid derivatives on clinical manifestations of inflammatory diseases of the uterus and its appendages].
Topics: Adult; Antioxidants; Female; Humans; Inflammation; Meglumine; Middle Aged; Pelvic Inflammatory Disease; Picolines; Prospective Studies; Succinates; Uterine Diseases | 2013 |
1 other study(ies) available for meglumine and Uterine Diseases
| Article | Year |
|---|---|
Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Contrast Media; Drug Combinations; Endometrial Neoplasms; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Myometrium; Organometallic Compounds; Pentetic Acid; Uterine Cervical Neoplasms; Uterine Diseases; Uterine Neoplasms; Uterus | 1992 |